BofA/Merrill Upgrades XRAY To Buy

Analysts at BofA/Merrill upgrade DENTSPLY International Inc
XRAY
from “neutral” to “buy.” The target price for XRAY is set to $40. XRAY shares gained 6.48% to $37.61 in pre-market trading.
More Analyst Ratings here
Loading...
Loading...
XRAY Logo
XRAYDentsply Sirona Inc
$15.36-0.26%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
14.77
Growth
13.11
Quality
1.19
Value
30.59
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Comments
Loading...